ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 270 filers reported holding ALKERMES PLC in Q2 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,929,500 | -1.5% | 1,461,246 | +10.0% | 0.24% | +0.8% |
| Q2 2023 | $41,562,926 | +13.3% | 1,327,889 | +2.0% | 0.24% | +6.7% |
| Q1 2023 | $36,685,874 | -2.8% | 1,301,379 | -9.9% | 0.22% | -11.8% |
| Q4 2022 | $37,728,219 | +5.2% | 1,443,866 | -10.1% | 0.26% | -9.9% |
| Q3 2022 | $35,849,000 | -27.2% | 1,605,405 | -2.9% | 0.28% | -25.7% |
| Q2 2022 | $49,275,000 | +6.9% | 1,654,069 | -5.5% | 0.38% | +22.9% |
| Q1 2022 | $46,073,000 | +20.1% | 1,751,156 | +6.2% | 0.31% | +20.6% |
| Q4 2021 | $38,351,000 | -28.2% | 1,648,802 | -4.8% | 0.26% | -28.6% |
| Q3 2021 | $53,423,000 | +27.1% | 1,732,278 | +1.1% | 0.36% | +26.3% |
| Q2 2021 | $42,030,000 | +59.2% | 1,714,117 | +21.3% | 0.28% | +39.7% |
| Q1 2021 | $26,399,000 | -0.6% | 1,413,199 | +6.2% | 0.20% | -12.4% |
| Q4 2020 | $26,546,000 | +14.5% | 1,330,618 | -4.9% | 0.23% | -2.9% |
| Q3 2020 | $23,193,000 | +1.0% | 1,399,702 | +18.3% | 0.24% | -3.6% |
| Q2 2020 | $22,962,000 | +64.6% | 1,183,308 | +22.3% | 0.25% | +39.1% |
| Q1 2020 | $13,953,000 | -25.6% | 967,631 | +5.2% | 0.18% | -2.7% |
| Q4 2019 | $18,757,000 | +45.2% | 919,465 | +38.8% | 0.18% | +15.7% |
| Q3 2019 | $12,921,000 | +38.3% | 662,259 | +59.8% | 0.16% | +23.3% |
| Q2 2019 | $9,343,000 | -56.9% | 414,522 | -30.2% | 0.13% | -58.8% |
| Q1 2019 | $21,664,000 | +69.6% | 593,706 | +37.2% | 0.31% | +39.7% |
| Q4 2018 | $12,771,000 | +26.5% | 432,776 | +82.0% | 0.22% | +56.6% |
| Q3 2018 | $10,094,000 | +83.6% | 237,846 | +78.1% | 0.14% | +66.3% |
| Q2 2018 | $5,498,000 | +2530.6% | 133,565 | +3599.9% | 0.09% | +2766.7% |
| Q1 2018 | $209,000 | -74.2% | 3,610 | -77.3% | 0.00% | -81.2% |
| Q3 2017 | $810,000 | +150.0% | 15,930 | +185.0% | 0.02% | +128.6% |
| Q2 2017 | $324,000 | -47.8% | 5,590 | -61.1% | 0.01% | -46.2% |
| Q2 2016 | $621,000 | -93.0% | 14,363 | -94.5% | 0.01% | -93.1% |
| Q1 2016 | $8,877,000 | +2229.9% | 259,631 | +3894.3% | 0.19% | +2250.0% |
| Q3 2015 | $381,000 | -17.0% | 6,500 | -9.0% | 0.01% | -11.1% |
| Q2 2015 | $459,000 | -49.1% | 7,140 | -51.8% | 0.01% | -40.0% |
| Q1 2015 | $902,000 | – | 14,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |